Zobrazeno 1 - 10
of 71
pro vyhledávání: '"E. P. Sharapova"'
Autor:
E. A. Taskina, L. I. Alekseeva, N. G. Kashevarova, E. A. Strebkova, E. P. Sharapova, N. M. Savushkina, K. M. Mikhailov, T. A. Raskina, I. B. Vinogradova, E. N. Otteva, E. V. Zonova, O. N. Anoshenkova, A. M. Lila
Publikováno v:
Современная ревматология, Vol 18, Iss 4, Pp 51-58 (2024)
Objective: to investigate in a multicenter study relationship between type 2 diabetes mellitus (DM) and clinical manifestations of osteoarthritis (OA). Material and methods. The study involved 767 patients aged 40–75 years with a confirmed diagnosi
Externí odkaz:
https://doaj.org/article/7caa582fe4a249a8826974b0a7884a20
Autor:
A. M. Lila, L. I. Alekseeva, E. A. Taskina, N. G. Kashevarova, E. P. Sharapova, E. A. Strebkova, N. M. Savushkina, A. R. Khalmetova, V. A. Nesterenko, A. S. Avdeeva, E. Yu. Samarkina, M. E. Diatroptov, O. G. Alekseeva
Publikováno v:
Современная ревматология, Vol 18, Iss 3, Pp 14-24 (2024)
Objective: to investigate the efficacy and safety of olokizumab (OKZ) in patients with knee osteoarthritis (OA) with synovitis, persistent pain and ineffectiveness of previous conservative therapy. Material and methods. The study included 15 patients
Externí odkaz:
https://doaj.org/article/a2d5570a9a8b437ea513c76f3516eedb
Autor:
N. G. Kashevarova, E. A. Taskina, E. A. Strebkova, E. P. Sharapova, N. M. Savushkina, T. A. Korotkova, L. I. Alekseeva, A. M. Lila
Publikováno v:
Современная ревматология, Vol 17, Iss 3, Pp 51-59 (2023)
Local forms of non-steroidal anti-inflammatory drugs (NSAIDs) are characterized by a high safety profile due to low systemic absorption. They do not increase the risk of developing class-specific gastrointestinal, cardiovascular and kidney adverse ev
Externí odkaz:
https://doaj.org/article/38ce1cd8c5bd4cf48279ac6f5b3b3fb3
Publikováno v:
Современная ревматология, Vol 16, Iss 6, Pp 98-105 (2022)
Osteoarthritis is the most common rheumatic disease, accompanied by constant pain and dysfunction of the joints, the progression of which leads to a deterioration in the quality of life and often to disability of patients. The article presents the pr
Externí odkaz:
https://doaj.org/article/b29b872431614d5a95ec8b637ed52b49
Publikováno v:
Современная ревматология, Vol 15, Iss 4, Pp 120-125 (2021)
Currently chondroitin sulfate (CS) is the most studied drug from the group of «chondroprotectors». The article shows the role of CS in the treatment of osteoarthritis (OA): mechanism of action, clinical efficacy and safety in patients with OA with
Externí odkaz:
https://doaj.org/article/eb0d8ed317034dfcbaf48f34db740145
Autor:
L. I. Alekseeva, E. A. Taskina, N. G. Kashevarova, E. P. Sharapova, E. A. Strebkova, S. G. Anikin, N. V. Chichasova, T. A. Raskina, E. V. Zonova, E. N. Otteva, E. I. Shmidt, S. P. Yakupova, I. B. Vinogradova, O. N. Ivanova, V. A. Lila, B. V. Zavadovsky, P. A. Shesternya, A. M. Lila
Publikováno v:
Современная ревматология, Vol 15, Iss 1, Pp 51-59 (2021)
Objective: to evaluate the efficacy and safety of glycosaminoglycan-peptide complex (GPC, Rumalon) used in patients with knee osteoarthritis (OA) and comorbidities (hypertension and/or type 2 diabetes mellitus (T2DM).Patients and methods: A 10-month
Externí odkaz:
https://doaj.org/article/404b7503d3784a2dace0b24ef3724136
Autor:
L. I. Alekseeva, N. G. Kashevarova, E. A. Taskina, E. P. Sharapova, S. G. Anikin, E. A. Strebkova, T. A. Raskina, E. V. Zonova, E. N. Otteva, S. S. Rodionova, A. N. Torgashin, U. V. Buklemishev, E. I. Shmidt, P. A. Shesternya, A. V. Naumov, N. V. Zagorodniy, A. M. Lila
Publikováno v:
Терапевтический архив, Vol 92, Iss 5, Pp 46-54 (2020)
in 3 mL on patients with knee osteoarthritis (OA) in a multicenter prospective study. Materials and methods. 79 outpatients (predominantly females 81.0%) from 5 RF constituent territories with primary tibiofemoral KellgrenLawrence score grade II or
Externí odkaz:
https://doaj.org/article/90e7d18331fc41e2aac6c3b0899d42c3
Autor:
E. V. Chetina, E. P. Sharapova
Publikováno v:
Современная ревматология, Vol 14, Iss 1, Pp 93-100 (2020)
Rheumatic diseases (RDs), including osteoarthritis and rheumatoid arthritis, are non-infectious slowly progressive incurable inflammatory diseases that lead to prolonged disability due to damage to the musculoskeletal system. Pain is a dominant sympt
Externí odkaz:
https://doaj.org/article/79caaa566a184cb99e6763abb61b26cd
Autor:
E. P. Sharapova, L. I. Alekseeva, E. A. Taskina, N. G. Kashevarova, S. G. Anikin, E. A. Strebkova, A. M. Lila, V. I. Mazurov, N. A. Shostak, E. I. Shmidt, E. P. Ilivanova
Publikováno v:
Современная ревматология, Vol 14, Iss 1, Pp 67-73 (2020)
Osteoarthritis (OA) belongs to diseases with high comorbidity and most frequently concurrent with obesity, diabetes mellitus (DM), hypertension, and other cardiovascular diseases (coronary heart disease, atherosclerosis), gastrointestinal tract disea
Externí odkaz:
https://doaj.org/article/f262bee1f0544acda945fa1252620e85
Autor:
E. P. Sharapova, L. I. Alekseeva
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 96-100 (2019)
Knee and hip joint pain is the first and most common symptom that forces a patient to visit the doctor. Osteoarthritis (OA) treatment is aimed «primarily» at managing symptoms of the disease, i.e. reducing pain, improving the functional state of th
Externí odkaz:
https://doaj.org/article/f87a95ecb261491eb1a439f5a422ceab